Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a new survey that was published on Friday. The new ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like Ozempic.

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

Based in New York, Metsera (MTSR) is developing oral and injectable medications for the treatment of obesity and related conditions. Its lead drug candidate, MTE-097i, is an ultra-long-acting GLP ...

Shares in Novo Nordisk were up nearly 12% today – hiking its valuation to more than $280 billion – after it reported new clinical data with one of its obesity drug candidates. The new results ...

Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, ...

The story of HCPs’ advocacy for the Treat and Reduce Obesity Act reveals a broader truth: HCPs care deeply about the ...

On 21 December of last year, the Danish pharmaceutical company experienced a 21% plunge in its share price following disappointing trial results for its new obesity drug, CagriSema. Amycretin is ...

The U.S. Food and Drug Administration (FDA) approved Ozempic in December 2017 for treating type 2 diabetes. The drug's ability to help people lose weight caused demand to skyrocket. In June 2021 ...